Aevitas Wealth Management, Inc. Abb Vie Inc. Transaction History

Aevitas Wealth Management, Inc.

$169 Million
Q4 2022

A detailed history of Aevitas Wealth Management, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Aevitas Wealth Management, Inc. holds 15,608 shares of ABBV stock, worth $3.18 Million. This represents 1.49% of its overall portfolio holdings.

Number of Shares

15,608

Previous 15,422 1.21%

Holding current value

$3.18 Million

Previous $2.07 Million 21.88%

% of portfolio

1.49%

Previous 1.56%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 24, 2023	BUY	$138.31 - $165.87 $25,725 - $30,851	186 Added 1.21%	15,608 $0
Q3 2022 Oct 24, 2022	BUY	$134.21 - $153.93 $3,086 - $3,540	23 Added 0.15%	15,422 $2.07 Million
Q2 2022 Jul 22, 2022	SELL	$137.62 - $174.96 $23,945 - $30,443	-174 Reduced 1.12%	15,399 $2.36 Million
Q1 2022 Apr 25, 2022	SELL	$131.98 - $163.75 $103,472 - $128,380	-784 Reduced 4.79%	15,573 $2.53 Million
Q4 2021 Jan 19, 2022	BUY	$107.43 - $135.93 $7,197 - $9,107	67 Added 0.41%	16,357 $2.22 Million
Q3 2021 Nov 01, 2021	SELL	$106.4 - $120.78 $13,938 - $15,822	-131 Reduced 0.8%	16,290 $1.76 Million
Q2 2021 Jul 22, 2021	BUY	$105.21 - $117.21 $65,019 - $72,435	618 Added 3.91%	16,421 $1.85 Million
Q1 2021 Apr 29, 2021	BUY	$102.3 - $112.62 $20,255 - $22,298	198 Added 1.27%	15,803 $1.71 Million
Q4 2020 Jan 19, 2021	BUY	$80.49 - $108.67 $69,140 - $93,347	859 Added 5.83%	15,605 $1.67 Million
Q3 2020 Oct 22, 2020	BUY	$85.91 - $100.83 $644,153 - $756,023	7,498 Added 103.45%	14,746 $1.29 Million
Q2 2020 Jul 29, 2020	BUY	$73.37 - $98.18 $216,148 - $289,238	2,946 Added 68.48%	7,248 $761,000
Q1 2020 Apr 16, 2020	BUY	$64.5 - $97.79 $774 - $1,173	12 Added 0.28%	4,302 $328,000
Q4 2019 Jan 31, 2020	BUY	$72.13 - $90.25 $29,501 - $36,912	409 Added 10.54%	4,290 $380,000
Q3 2019 Oct 21, 2019	SELL	$62.98 - $75.72 $18,201 - $21,883	-289 Reduced 6.93%	3,881 $294,000
Q2 2019 Jul 26, 2019	SELL	$65.7 - $83.98 $89,417 - $114,296	-1,361 Reduced 24.61%	4,170 $303,000
Q1 2019 May 09, 2019	BUY	$77.14 - $90.79 $235,122 - $276,727	3,048 Added 122.75%	5,531 $445,000
Q4 2018 Feb 14, 2019	SELL	$77.85 - $96.01 $7,240 - $8,928	-93 Reduced 3.61%	2,483 $229,000
Q3 2018 Nov 14, 2018	SELL	$88.91 - $98.84 $34,941 - $38,844	-393 Reduced 13.24%	2,576 $244,000
Q2 2018 Aug 10, 2018	BUY	$89.78 - $106.23 $448 - $531	5 Added 0.17%	2,969 $275,000
Q1 2018 May 15, 2018	BUY	$92.01 - $123.21 $4,968 - $6,653	54 Added 1.86%	2,964 $280,000
Q4 2017 Feb 13, 2018	BUY	$89.56 - $98.21 $260,619 - $285,791	2,910	2,910 $281,000

Others Institutions Holding ABBV

# of Institutions

3,767

Shares Held

1.28B

Call Options Held

13M

Put Options Held

9.83M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $360B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aevitas Wealth Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Aevitas Wealth Management, Inc. with notifications on news.

Account

Aevitas Wealth Management, Inc. Abb Vie Inc. Transaction History